Returning in a fully digital format, the 6th Dry AMD & Geographic Atrophy Therapeutics Summit offers three dynamic days of cutting-edge content and curated networking, connecting global stakeholders across biotech, pharma, academia, and investment.

The program delivers cross-functional insights for advancing therapies from early discovery to late-stage development, featuring expert-led panels, clinical case studies, investor discussions, and regulatory workshops.

Attendees will gain practical strategies on trial design, emerging endpoints, delivery technologies, and funding. With interactive sessions and virtual networking, this summit offers an unmatched opportunity to collaborate and accelerate dry AMD and GA programs without geographic barriers.

‍

‍